Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and Exenatide in Type 2 Diabetes (PIO-EX)
NCT00845182Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Jun 2007
- Primary completion
- Jul 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone, exenatide in type 2 diabetes mellitus (T2DM), sponsored by UT Health San Antonio. Started Jun 2007; status: completed.
02
Drugs
pioglitazoneexenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00845182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845182.